Literature DB >> 7039267

Mechanisms of action of gold.

J H Leibfarth, R H Persellin.   

Abstract

Since the successful introduction of injectable gold compounds for the treatment of rheumatoid arthritis over 50 years ago, numerous studies on the possible mechanism of action have been performed. This heavy metal has been show to possess a bewildering array of biological effects. Studies using gold performed both in vitro and in vivo can be grouped into anti-microbial, anti-immunologic, anti-inflammatory, anti-enzymatic and other effects. In this survey, we have analyzed these multiple approaches to the study of the mechanism of action of injectable gold preparations and apply the findings to rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7039267     DOI: 10.1007/bf02004707

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  117 in total

1.  Suppressive effects of metal salts on leukocyte and fibroblastic function.

Authors:  P A Ward; P Goldschmidt; N D Greene
Journal:  J Reticuloendothel Soc       Date:  1975-11

2.  Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases.

Authors:  R S Ennis; J L Granda; A S Posner
Journal:  Arthritis Rheum       Date:  1968-12

3.  Response of rheumatoid arthritis with leukopenia to gold salts.

Authors:  J D Gowans; M Salami
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

4.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

5.  Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes.

Authors:  B M Sutton; E McGusty; D T Walz; M J DiMartino
Journal:  J Med Chem       Date:  1972-11       Impact factor: 7.446

6.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

7.  Reaction of gold with collagen in vivo.

Authors:  M Adam; P Bartl; Z Deyl; J Rosmus
Journal:  Experientia       Date:  1964-04-15

8.  Influence of antirheumatic agents on the release of histamine from rat peritoneal mast cells after an antigen-antibody reaction.

Authors:  S Norn
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

9.  Gold-induced changes in the morphology and functional capabilities of human monocytes.

Authors:  K Ugai; M Ziff; P E Lipsky
Journal:  Arthritis Rheum       Date:  1979-12

10.  Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone.

Authors:  K J Stone; S J Mather; P P Gibson
Journal:  Prostaglandins       Date:  1975-08
View more
  5 in total

1.  Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis.

Authors:  D R Haynes; I R Garrett; B Vernon-Roberts
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 2.  Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.

Authors:  Michael Whitehouse; Desley Butters; Barrie Vernon-Roberts
Journal:  Inflammopharmacology       Date:  2013-05-19       Impact factor: 4.473

3.  In vitro and in vivo effects of gold salts on chemotaxis and random migration of rat polymorphonuclear leucocytes.

Authors:  D Pham Huy; M Roch-Arveiller; O Muntaner; J P Giroud
Journal:  Agents Actions       Date:  1985-07

4.  Urticarial vasculitis--response to gold therapy.

Authors:  S E Handfield-Jones; M W Greaves
Journal:  J R Soc Med       Date:  1991-03       Impact factor: 18.000

Review 5.  Prospecting Cellular Gold Nanoparticle Biomineralization as a Viable Alternative to Prefabricated Gold Nanoparticles.

Authors:  Aaron S Schwartz-Duval; Konstantin V Sokolov
Journal:  Adv Sci (Weinh)       Date:  2022-05-04       Impact factor: 17.521

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.